We have located links that may give you full text access.
DRG Based Payments for Adult Spine Deformity Surgery Significantly Vary across Centers: Results from a multicenter prospective cohort study.
World Neurosurgery 2022 November 29
BACKGROUND: To investigate the variation in total episode of care (EOC) payment and quality adjusted life year (QALY) gain for complex adult spine deformity (ASD) surgeries in the U.S. adjusting for case type and surgeon preferences.
METHODS: ASD patients aged > 18 years with MS-DRGs 453-460 and a minimum of two-years of follow-up from index surgery were included. Index and total payments were calculated using Medicare's inpatient prospective payment system (IPPS). All costs were adjusted for inflation to 2020 US dollar values. QALYs gained were calculated using baseline, 1-year, and 2-year Short-Form 6D (SF-6D) scores. Mixed-effect models were used to estimate the proportion of variation in total EOC payment and QALY gain.
RESULTS: A total of 330/ 543 patients from six sites were included. Mean age was 62.4+11.9 years, 79% were women, and 92% were Caucasian. The mean index and total EOC payment were $77,302 and $93,182, respectively. Patients gained on average 0.15 QALY (p<0.0001) two years following surgery. In unadjusted analysis, 39% of the variation in total EOC payment across the six centers was attributable to relative weight of DRG and base rate. Adjusting for patient and procedural factors increased the proportion of variation in total EOC payments across the centers to 56%. Less than 2% of the variation in QALY gain was observed across the six centers.
CONCLUSIONS: Medicare-based payments for complex spine deformity fusions are primarily driven by relative weight of the DRG and the hospital's base rate. Patient and procedural factors are unaccounted for in the DRG-based payments made to the providers.
METHODS: ASD patients aged > 18 years with MS-DRGs 453-460 and a minimum of two-years of follow-up from index surgery were included. Index and total payments were calculated using Medicare's inpatient prospective payment system (IPPS). All costs were adjusted for inflation to 2020 US dollar values. QALYs gained were calculated using baseline, 1-year, and 2-year Short-Form 6D (SF-6D) scores. Mixed-effect models were used to estimate the proportion of variation in total EOC payment and QALY gain.
RESULTS: A total of 330/ 543 patients from six sites were included. Mean age was 62.4+11.9 years, 79% were women, and 92% were Caucasian. The mean index and total EOC payment were $77,302 and $93,182, respectively. Patients gained on average 0.15 QALY (p<0.0001) two years following surgery. In unadjusted analysis, 39% of the variation in total EOC payment across the six centers was attributable to relative weight of DRG and base rate. Adjusting for patient and procedural factors increased the proportion of variation in total EOC payments across the centers to 56%. Less than 2% of the variation in QALY gain was observed across the six centers.
CONCLUSIONS: Medicare-based payments for complex spine deformity fusions are primarily driven by relative weight of the DRG and the hospital's base rate. Patient and procedural factors are unaccounted for in the DRG-based payments made to the providers.
Full text links
Related Resources
Trending Papers
Advances in Clinical Cardiology 2023: A Summary of Key Clinical Trials.Advances in Therapy 2024 May 15
Nutrition in the intensive care unit: from the acute phase to beyond.Intensive Care Medicine 2024 May 22
The Therapy and Management of Heart Failure with Preserved Ejection Fraction: New Insights on Treatment.Cardiac Failure Review 2024
Sodium-glucose co-transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes.Cochrane Database of Systematic Reviews 2024 May 22
Bronchiectasis management in adults: state of the art and future directions.European Respiratory Journal 2024 May 24
Drug Therapy for Acute and Chronic Heart Failure with Preserved Ejection Fraction with Hypertension: A State-of-the-Art Review.American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions 2024 April 5
Pathophysiological Link and Treatment Implication of Heart Failure and Preserved Ejection Fraction in Patients with Chronic Kidney Disease.Biomedicines 2024 April 31
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app